Editorial: Pulmonary Hypertension: Mechanisms and Management, History and Future

A A Roger Thompson^{1

2}, Martin R Wilkins³, Jim M Wild^{1

4

5}, David G Kiely^{1

2

5}, Allan Lawrie^{1

5}

Affiliations

¹ Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.
² Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
³ Department of Medicine and National Heart and Lung Institute, Imperial College London, London, United Kingdom.
⁴ POLARIS, Academic Unit of Radiology, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
⁵ INSIGNEO Institute for in silico Medicine, The University of Sheffield, Sheffield, United Kingdom.

Editorial

A A Roger Thompson et al. Front Med (Lausanne). 2020.

. 2020 Apr 21:7:125.

doi: 10.3389/fmed.2020.00125. eCollection 2020.

A A Roger Thompson^{1

2}, Martin R Wilkins³, Jim M Wild^{1

4

5}, David G Kiely^{1

2

5}, Allan Lawrie^{1

5}

¹ Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.
² Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
³ Department of Medicine and National Heart and Lung Institute, Imperial College London, London, United Kingdom.
⁴ POLARIS, Academic Unit of Radiology, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
⁵ INSIGNEO Institute for in silico Medicine, The University of Sheffield, Sheffield, United Kingdom.

No abstract available

Keywords: biomarkers; heart failure; imaging; pulmonary hypertension; screening tools; therapeutics.

Comment on

Editorial on the Research Topic Pulmonary Hypertension: Mechanisms and Management, History and Future

1. Heath D. Travellers on a Hidden River. J Med Biogr. (1998) 6:105–113. 10.1177/096777209800600208 - DOI - PubMed
1. Heath D, Whitaker W. Hypertensive pulmonary vascular disease. Circulation. (1956) 14:323–43. 10.1161/circ.14.3.323 - DOI - PubMed
1. Quadery SR, Swift AJ, Billings CG, Thompson AAR, Elliot CA, Hurdman J, et al. . The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension. Eur Respir J. (2018) 52:1800589. 10.1183/13993003.00589-2018 - DOI - PMC - PubMed
1. National Audit of Pulmonary Project Board National Audit of Pulmonary Hypertension, 10th Annual Report - NHS Digital. (2019). Available online at: https://digital.nhs.uk/data-and-information/publications/statistical/nat... (accessed November 24, 2019).
1. Bergemann R, Allsopp J, Jenner H, Drage E, Samyshkin Y, Schmitt C, et al. . High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project. Pulm Circ. (2018) 8:1–9. 10.1177/2045894018798613 - DOI - PMC - PubMed